About Chargepoint

The ChargePoint® valve was originally developed in conjunction with Glaxo Pharmaceuticals (now GlaxoSmithKline) in 1996. Previously known as Contained Transfer Coupling (CTC), the fundamental features of the valve are still retained in the design as it stands today.

The precision engineered, patented technology has now become a pharmaceutical industry standard for high containment batch transfers. The ChargePoint® valve is a common solution for contained charging/filling or discharging/dispensing of potent compounds from a wide variety of pharmaceutical and chemical process equipment: from reactors and isolators to mixing and tablet pressing equipment.

The flexibility of the ChargePoint® split valve design has now enabled it to be applied within other areas of the pharmaceutical production process, for example bulk formulations, aseptic processes or steam in place as well as other markets such as the Beverage industry.

 

Time Line Update Vertical 01

 

Our Customers 

Our customers include the top 20 global Pharmaceutical companies and many other:

  • End users (manufacturers)
  • Original Equipment Manufacturers (OEM's) and integrators
  • Engineering consultants and service providers

Clients 01